Showing results (691-700 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|January 1, 1984
Selective extraction by 1-butanol of surface glycoprotein antigens from human melanoma cellsS K Liao, J W Smith, P C KwongCancer Immunology, Immunotherapy : CII|January 1, 1983
Monoclonal antibodies to different epitopes on a prostate tumor-associated antigen. Implications for immunotherapyK S Webb, J L Ware, S F Parks, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1983
Adriamycin-induced activation of NK activity may initially involve LAF productionS A Cohen, D Salazar, J WicherCancer Immunology, Immunotherapy : CII|January 1, 1983
Antitumor activity of living or killed Brucella: modification of the non-specific cytotoxic effector cellsL Dazord, Y le Garrec, I FlorentinCancer Immunology, Immunotherapy : CII|January 1, 1984
Peripheral T gamma lymphocyte population in head and neck cancerY Hayashi, T Nishida, H Yoshida, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1984
In vitro effects of 4-hydroperoxycyclophosphamide on concanavalin A-induced human suppressor T cellsA Klajman, I Drucker, Y Manor, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1984
Absence of generalized immunosuppression in C57BL/6J mice implanted with Lewis T241 fibrosarcoma or Lewis lung carcinomaC E Jones, C T Lee, W Skinner, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1984
Deficient expression of class-I HLA in some cases of acute leukemiaW L Elkins, A Pickard, G R PiersonCancer Immunology, Immunotherapy : CII|January 1, 1983
Supernatant derived from a human hepatocellular carcinoma cell line (PLC/PRF/5) activates a population of T-suppressor cellsA Keong, A R RabsonCancer Immunology, Immunotherapy : CII|January 1, 1983
Assessment of in vivo natural antitumor resistance and lymphocyte. Migration in mice: comparison of 125I-iododeoxyuridine with 111indium-oxine and 51chromium as cell labelsR H Wiltrout, E Gorelik, M J Brunda, et al.Pageof 650